Freeport-McMoRan Inc. (FCX) Market Cap & Valuation Ratios
Freeport-McMoRan Inc. (FCX) has a market cap of $93.6B, a trailing P/E of 32.0 and a price-to-sales ratio of 3.6, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FCXFreeport-McMoRan Inc.Follow FCX — free
—
Price chart with a free account
- Market cap
- 93.6B
- P/E TTM
- 32.0
- Dividend yield
- 0.9%
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Peers
copper · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| FCX | 94 | 32.0 | 3.8 | 10.9 | 1.9% | +0.2% | 27% | 20% |
| LIN | 235 | 32.8 | 7.3 | 19.5 | 2.1% | +7% | 26% | 12% |
| SCCO | 154 | 27.2 | 9.8 | 15.7 | 3.3% | +33% | 57% | 40% |
| NEM | 113 | 12.7 | 4.1 | 6.5 | 8.9% | +24% | 53% | 27% |
| SHW | 82 | 31.1 | 3.8 | 19.8 | 3.9% | +6% | 16% | 20% |
| ECL | 81 | 38.7 | 5.3 | 22.9 | 2.3% | +7% | 17% | 14% |
| APD | 68 | — | 6.8 | 89.5 | -0.4% | +5% | -5% | -2% |
| NUE | 59 | 20.6 | 1.7 | 10.9 | 2.7% | +17% | 12% | 13% |
| CRH | 56 | 15.0 | 1.8 | 9.1 | 4.9% | +6% | 14% | 11% |
| AU | 42 | 11.2 | 4.1 | — | 7.9% | +71% | 45% | 35% |
| IE | 1.3 | — | 341.6 | 60.7 | -8.8% | -21% | — | 4% |
| Median of these 10 | 23.9 | 4.7 | 19.5 | 3.0% | +7% | 17% | 13% |
P/E 32.0 vs. a peer median of 23.9; EV/Sales 3.8 vs. 4.7. FCX's own P/E sits at the 61st percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesAPD and IE have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Freeport-McMoRan Inc. — questions
- What is Freeport-McMoRan Inc.'s market cap?
- $93.6B.
- What is Freeport-McMoRan Inc.'s P/E ratio?
- 32.0 on trailing twelve-month earnings to 2026-06-30.
- What is Freeport-McMoRan Inc.'s price-to-sales ratio?
- 3.6.
Every figure on this page comes from Freeport-McMoRan Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.